Key Brain Receptors Linked To Learning and Memory Decrease with Age

September 11, 2009 Key Brain Receptors Linked To Learning and Memory Decrease with Age

Enlarge

(PhysOrg.com) -- Scientists studying cognitive decline that accompanies aging have been interested in nicotinic receptors, part of a key neural pathway that not only enhances learning and memory skills but reinforces addictions as well. The loss of these receptors has been difficult to study in living subjects, but Yale University researchers using advanced imaging technology have successfully tracked the loss of receptors with age, according to a report in the September issue of the journal Neurobiology of Aging.

“Measurable decline in cognitive abilities is evident by 50, but our knowledge of the changes in the brain associated with these deficits has been largely confined to post-mortem studies,” said Christopher H. van Dyck, senior author of the study and Professor of Psychiatry and Neurobiology and Director of the Alzheimer’s Disease Research Unit.

The Yale University researchers used SPECT imaging to track concentrations of nicotinic receptors in eight brain regions of 47 subjects aged 18 to 85. They observed an age-related loss of receptors in seven of eight brain regions, at a rate of about 5 percent per decade of life.

Nicotinic receptors reinforce addictions such as smoking, but also facilitate learning and memory. Autopsies of patients have revealed a significant decline of these receptors.

“Nicotinic receptors are such promising targets that pharmaceutical companies are currently exploring nicotine analogues as potential treatments for Alzheimer’s disease and Mild Cognitive Impairment,” van Dyck said.

The findings are additional evidence that nicotinic receptors may play a role in the cognitive decline associated with normal aging. “These results may encourage the broadening of therapeutic trials to target the associated with healthy aging,” van Dyck said.

Other Yale authors of the paper are Effie M. Mitsis, Kelly P. Cosgrove, Julie K. Staley, Frederic Bois, Erin B. Frohlich, Gilles D. Tamagnan, Kristina M. Estok and John P. Seibyl.

Provided by Yale University (news : web)


print this article email this article download pdf blog this article bookmark this article     Stumble it Digg this share on Facebook retweet share on Reddit add to delicious
Rate this story - 5 /5 (5 votes)


September 11, 2009 all stories

Comments: 0

5 /5 (5 votes)
  • Stumble this up

  • Digg this

  • share this

  • hide
  • Related Stories




  • hide
  • Relevant PhysicsForums posts

  • 23 Years in a Vegetative State....or not?
    created 19 hours ago
  • Has the H1N1 vaccine been scientifically proven to work?
    created Nov 24, 2009
  • nesfatin
    created Nov 22, 2009
  • Obsessive Compulsive Disorder
    created Nov 20, 2009
  • More from Physics Forums - Medical Sciences

Other News

Estrogen receptor-alpha, breast cancer patients and tamoxifen response

Medicine & Health / Cancer

created 48 minutes ago | popularity not rated yet | comments 0

Researchers have found evidence of a statistically significant survival benefit from adjuvant tamoxifen among patients whose estrogen receptor (ER)-positive tumors had high levels of phosphorylation of ER-alpha; at serine-118 ...


Implant-based cancer vaccine is first to eliminate tumors in mice

Implant-based cancer vaccine is first to eliminate tumors in mice

Medicine & Health / Cancer

created 6 hours ago | popularity 5 / 5 (9) | comments 2

(PhysOrg.com) -- A cancer vaccine carried into the body on a carefully engineered, fingernail-sized implant is the first to successfully eliminate tumors in mammals, scientists report this week in the journal ...


Brain's endocannabinoid signaling pathway kept in check by two enzymes

Medicine & Health / Research

created 3 hours ago | popularity 5 / 5 (2) | comments 0

(PhysOrg.com) -- A research team has shown that blocking the degradation of two naturally occurring cannabinoids in the endocannabinoid signaling pathway of the brain produces marijuana-like behavioral effects in mice, according ...


Engineers, doctors develop novel material that could help fight arterial disease

Medicine & Health / Research

created 2 hours ago | popularity not rated yet | comments 0

A fortuitous discovery that grew out of a collaboration between UCLA engineers and physicians could potentially offer hope to the nearly 10 million Americans who suffer from peripheral arterial disease.


Free e-samples of prescription drugs: At what cost?

Medicine & Health / Health

created 3 hours ago | popularity 5 / 5 (1) | comments 0

Search the Internet to learn about your asthma, high cholesterol or other common disorder, and odds are you'll be directed to a pharmaceutical company-sponsored Web homepage. There you'll often find an offer for a free sample ...